Pharmaceutical Distribution
•44 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (44)
| Company | Market Cap | Price |
|---|---|---|
|
AMZN
Amazon.com, Inc.
Amazon Pharmacy as prescription fulfillment and distribution service.
|
$2.54T |
$238.57
+0.17%
|
|
MCK
McKesson Corporation
McKesson's core business is pharmaceutical distribution, directly tied to pharmaceutical distribution activities.
|
$105.00B |
$840.26
-0.46%
|
|
UPS
United Parcel Service, Inc.
Healthcare/pharmaceutical distribution logistics is a strategic growth focus.
|
$92.06B |
$107.56
-0.98%
|
|
ELV
Elevance Health Inc.
Pharmaceutical Distribution – CarelonRx/Paragon Specialty Pharmacy activities include distribution and specialty pharmacy services.
|
$86.00B |
$374.61
-1.92%
|
|
COR
Cencora, Inc.
Direct core business is pharmaceutical distribution (including temperature-controlled logistics and 3PL services).
|
$65.70B |
$339.62
+0.55%
|
|
CAH
Cardinal Health, Inc.
Cardinal Health's core pharmaceutical distribution business.
|
$50.97B |
$212.54
-0.43%
|
|
CHWY
Chewy, Inc.
Chewy Health pharmacy services include distribution of medicines to consumers.
|
$13.59B |
$33.73
+2.91%
|
|
WBA
Walgreens Boots Alliance, Inc.
Pharmaceutical Distribution – Walgreens distributes prescription and OTC medications through its store network and supply chain.
|
$10.36B |
$11.98
|
|
GXO
GXO Logistics, Inc.
GXO's healthcare-focused distribution, including NHS contracts, fits Pharmaceutical Distribution.
|
$6.54B |
$56.72
-0.74%
|
|
AMRX
Amneal Pharmaceuticals, Inc.
AvKARE distribution channel expands government/institutional pharmaceutical distribution.
|
$4.14B |
$13.20
+0.04%
|
|
GRND
Grindr Inc.
Woodwork represents a health/wellness service (pharmaceutical distribution and ED-related products) expansion.
|
$2.38B |
$12.26
-1.33%
|
|
GRDN
Guardian Pharmacy Services, Inc.
Pharmaceutical distribution capabilities inherent in pharmacy services (prescription intake, dispensing, packaging, and delivery to LTCFs).
|
$1.87B |
$28.53
-3.29%
|
|
HROW
Harrow Health, Inc.
Distribution and access strategy (VAFA, Apollo Care) to get products to payers and providers; indicates pharmaceutical distribution.
|
$1.79B |
$48.66
+0.35%
|
|
SPRY
ARS Pharmaceuticals, Inc.
ARS Pharma distributes pharmaceutical products (neffy) through direct sales and payer networks, aligning with Pharmaceutical Distribution.
|
$1.10B |
$11.36
+1.88%
|
|
TLRY
Tilray Brands, Inc.
Pharmaceutical distribution network in Germany via CC Pharma.
|
$1.09B |
$9.49
-2.27%
|
|
KMDA
Kamada Ltd.
Kamada distributes pharmaceutical products via partnerships (KEDRAB, GLASSIA) indicating Pharmaceutical Distribution activities.
|
$472.69M |
$8.20
-0.24%
|
|
ETON
Eton Pharmaceuticals, Inc.
ETON operates distribution for its therapies through Eton Cares and Optime Care, capturing pharmaceutical distribution activities.
|
$413.26M |
$15.35
-0.39%
|
|
AHG
Akso Health Group
Direct sales/distribution of pharmaceuticals and health products via online hospital network.
|
$366.69M |
$1.54
+0.65%
|
|
AQST
Aquestive Therapeutics, Inc.
Libervant and allied products involve pharmaceutical distribution to national retail channels, reflecting a current distribution revenue stream.
|
$333.08M |
$3.35
+0.30%
|
|
TOI
The Oncology Institute, Inc.
Dispensary segment includes specialty pharmacy distribution of oral and self-injectable medications.
|
$314.18M |
$3.44
+2.38%
|
|
SY
So-Young International Inc.
Exclusive distribution rights for PLLA products indicate a pharmaceutical/biotech distribution angle associated with medical aesthetics.
|
$263.20M |
$2.70
+1.89%
|
|
OMI
Owens & Minor, Inc.
OMI directly distributes pharmaceuticals as part of its healthcare distribution and patient-direct supply network.
|
$216.57M |
$2.80
|
|
DERM
Journey Medical Corporation
The company commercializes prescription products through a field-based distribution/sales network, i.e., pharmaceutical distribution.
|
$203.80M |
$8.03
-3.95%
|
|
LFMD
LifeMD, Inc.
In-house national pharmacy and pharmaceutical distribution, including compounding and GLP-1 therapies.
|
$178.76M |
$3.84
+1.86%
|
|
TNXP
Tonix Pharmaceuticals Holding Corp.
Upsher Smith-derived migraine products Zembrace SymTouch and Tosymra provide revenue through pharmaceutical distribution of migraine therapies.
|
$139.38M |
$16.46
+3.55%
|
|
STIM
Neuronetics, Inc.
SPRAVATO buy-and-bill rollout implies pharmaceutical distribution and reimbursement activities within clinics.
|
$119.69M |
$1.94
+6.91%
|
|
CPIX
Cumberland Pharmaceuticals Inc.
CPIX commercializes branded prescription pharmaceuticals via distribution channels to hospitals and clinics.
|
$71.21M |
$4.74
-0.42%
|
|
YI
111, Inc.
Core business of distributing pharmaceutical products across supply chains with temperature-controlled logistics.
|
$49.64M |
$5.83
+1.84%
|
|
COSG
Cosmos Group Holdings Inc.
COSG's partnerships for pharmaceutical/nutraceutical distribution across UAE, Albania, Qatar, GCC indicate pharma distribution capabilities.
|
$45.86M |
$0.00
|
|
ETST
Earth Science Tech, Inc.
Involves distribution of pharmaceutical products, including compounded medications from its pharmacies.
|
$38.25M |
$0.13
|
|
WGRX
Wellgistics Health, Inc.
Wellgistics Health operates a NABP-accredited pharmaceutical wholesale distributor serving independent pharmacies, a core pharmaceutical distribution business.
|
$34.32M |
$0.40
-1.79%
|
|
AYTU
Aytu BioPharma, Inc.
The business includes pharmaceutical distribution/fulfillment through RxConnect and its network of partner pharmacies.
|
$27.36M |
$2.65
-3.99%
|
|
CJMB
CALLAN JMB INC.
CJMB operates pharmaceutical distribution capabilities within its cold chain logistics and life sciences services.
|
$18.82M |
$3.58
-14.64%
|
|
NXPL
NextPlat Corp
NextPlat's healthcare segment includes pharmaceutical distribution and pharmacy services.
|
$18.70M |
$0.72
-0.21%
|
|
EVOK
Evoke Pharma, Inc.
Evoke commercializes Gimoti through distribution and market-access networks (e.g., Eversana and pharmacy partnerships), aligning with Pharmaceutical Distribution as a service.
|
$17.07M |
$10.98
+0.32%
|
|
COSM
Cosmos Health Inc.
Operates pharmaceutical distribution capabilities and related networks, including exclusive UAE distribution for Sky Premium Life products.
|
$16.37M |
$0.52
-3.19%
|
|
BMGL
Basel Medical Group Ltd Ordinary Shares
BMGL signed a large contract to supply essential healthcare products in Asia-Pacific, implying pharmaceutical/medical supply distribution.
|
$15.32M |
$0.83
+0.29%
|
|
ELTP
Elite Pharmaceuticals, Inc.
Elite has shifted to direct sales under its own label, functioning as a pharmaceutical distributor to end customers.
|
$13.94M |
$0.48
|
|
SCNX
Scienture Holdings, Inc.
Commercialization and distribution of pharmaceutical products imply involvement in Pharmaceutical Distribution.
|
$8.43M |
$0.53
+0.82%
|
|
IMRN
Immuron Limited
Pharmaceutical distribution for Travelan across pharmacies and networks (Passport Health US).
|
$6.10M |
$1.08
+0.93%
|
|
SNOA
Sonoma Pharmaceuticals, Inc.
Distribution networks for pharmaceutical/HOCl products (e.g., Medline, WellSpring).
|
$5.37M |
$3.25
-0.61%
|
|
CPHI
China Pharma Holdings, Inc.
Pharmaceutical distribution capability via established regional network.
|
$5.07M |
$1.55
-0.26%
|
|
INIS
International Isotopes Inc.
Distributes FDA-approved radiopharmaceutical products domestically, a core revenue stream.
|
$677144 |
$0.07
|
|
EMMA
Emmaus Life Sciences, Inc.
Emmaus distributes Endari through distributors and specialty pharmacies, indicating direct pharmaceutical distribution activity.
|
$14040 |
$0.01
|
Loading company comparison...
Loading industry trends...
Loading research report...
